Genmab A/S (GNMSF)
337.00
+9.30
(+2.84%)
USD |
OTCM |
Aug 25, 16:00
Genmab Total Assets (Quarterly) : 12.52B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.52B |
| March 31, 2026 | 12.38B |
| December 31, 2025 | 12.87B |
| September 30, 2025 | 7.021B |
| June 30, 2025 | 6.464B |
| March 31, 2025 | 6.586B |
| December 31, 2024 | 6.361B |
| September 30, 2024 | 5.938B |
| June 30, 2024 | 5.550B |
| March 31, 2024 | 5.311B |
| December 31, 2023 | 5.229B |
| September 30, 2023 | 5.003B |
| June 30, 2023 | 4.686B |
| March 31, 2023 | 4.433B |
| December 31, 2022 | 4.323B |
| September 30, 2022 | 4.043B |
| June 30, 2022 | 3.863B |
| March 31, 2022 | 3.727B |
| December 31, 2021 | 3.765B |
| September 30, 2021 | 3.738B |
| June 30, 2021 | 3.585B |
| March 31, 2021 | 3.510B |
| December 31, 2020 | 3.475B |
| September 30, 2020 | 3.390B |
| June 30, 2020 | 3.117B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.250B |
| December 31, 2019 | 2.275B |
| September 30, 2019 | 1.946B |
| June 30, 2019 | 1.370B |
| March 31, 2019 | 1.314B |
| December 31, 2018 | 1.296B |
| September 30, 2018 | 1.153B |
| June 30, 2018 | 1.128B |
| March 31, 2018 | 1.119B |
| December 31, 2017 | 1.065B |
| September 30, 2017 | 936.52M |
| June 30, 2017 | 924.79M |
| March 31, 2017 | 777.48M |
| December 31, 2016 | 743.06M |
| September 30, 2016 | 656.97M |
| June 30, 2016 | 616.45M |
| March 31, 2016 | 598.22M |
| December 31, 2015 | 568.07M |
| September 30, 2015 | 523.87M |
| June 30, 2015 | 490.46M |
| March 31, 2015 | 456.48M |
| December 31, 2014 | 465.84M |
| September 30, 2014 | 480.41M |
| June 30, 2014 | 499.14M |
| March 31, 2014 | 515.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ascendis Pharma A/S | 2.614B |
| Zealand Pharma A/S | 3.023B |
| Bavarian Nordic A/S | 2.252B |
| Evaxion AS | 19.38M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.558B |
| Shareholders Equity (Quarterly) | 5.957B |
| Debt to Equity Ratio | 0.8852 |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -6.25% |